This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.
2021-03-31-accounts
| CONTENTS |
Page |
| LegalandAdministration |
|
| Chairman'sSummary |
2 |
| Trustees'Report |
3-11 |
| IndependentAuditors'Report |
12-13 |
| StatementofFinancialActivities |
14 |
| BalanceSheet |
15 |
| StatementofCashFlows |
16 |
| NotestotheFinancialStatements |
17-24 |
U ChangingLivesThrough - **LEGAL AND ADMINISTRATION ** |
py Research |
| **TRUSTEES ** |
HenryRichard GeersCotterell(Chairman) |
|
ReshmaAshrafMason |
|
GuyEdmundSangster |
|
JemmaFreeman |
|
AlexanderJohns |
|
SaffronGuy |
| **COMPANY SECRETARY ** |
ReshmaAshrafMason |
| **REGISTERED OFFICE ** |
BrydenJohnsonLimited |
|
I-4 Kings Parade |
|
LowerCoombeStreet |
|
Croydon |
|
CR0IAA |
| **DIRECTOR ** |
MarieDimond |
|
Unit15 |
|
AbbevilleMews |
|
88ClaphamParkRoad |
|
London |
|
SW47BX |
| **SECRETARY TO TRUSTEES ** |
Abigail Parry-Williams |
| **Fl ANCIAL ADVISOR ** |
DavidMcCormick |
| **AUDITORS ** |
BrydenJohnsonLimited |
|
I-4KingsParade |
|
LowerCoombeStreet |
|
Croydon |
|
CRO!AA |
| **SOLICITORS ** |
Ashurst |
|
Broadwalk House |
|
5AppoldStreet |
|
LondonEC2A2HA |
| **PRINCIPAL BA~KERS ** |
BarclaysBankpie |
|
KensingtonandChelsea |
|
POBox4599 |
|
LondonSW3!XE |
| **INVESTMENT MANAGERS ** |
Cazenave CapitalManagement |
|
12Moorgate |
|
London |
|
EC2R6DA |
| **GOVERJ'IING DOCUMENT ** |
TheMemorandumandArticlesofAssociationincorporated26ovember |
|
1999as amended byspecialresolution dated30March 2000 |
|
I |
2021 |
**2020 ** |
| **Total Income ** |
|
**£685,032 ** |
**£620,431 ** |
| **Net (Deficit)/Gains including Investment Gains ** |
|
**£(109,147) ** |
**£(320,572) ** |
| **Net Assets ** |
|
**£1,574,102 ** |
**£1,683,249 ** |
| **Unrestricted Funds ** |
|
**£1,351,918 ** |
**£1,462,348 ** |
|
|
**Unrestricted ** |
**Restricted ** |
**Total ** |
|
|
|
**Funds ** |
**Funds ** |
**Funds ** |
|
|
|
**2021 ** |
**2021 ** |
**2021 ** |
**2020 ** |
|
**Notes ** |
£ |
£ |
£ |
£ |
| **lNCOME FROM: ** |
|
|
|
|
|
| **Donations andlegacies ** |
|
221,976 |
460,938 |
682,914 |
590,781 |
| Charitable activities |
|
|
|
|
|
| Symposium |
|
|
|
|
19,058 |
| Investmentincome |
|
2,118 |
|
2,118 |
10,592 |
| **Total income ** |
|
224,094 |
460,938 |
685,032 |
620,431 |
| **EXPENDITUREON: ** |
|
|
|
|
|
| Raisingfunds |
|
65,478 |
|
65,478 |
73,022 |
| Charitable activities |
|
269,046 |
459,655 |
728,701 |
867,981 |
| **Total expenditure ** |
2 |
334,524 |
459,655 |
794,179 |
941,003 |
| **Net income/ (expenditure) before investment ** |
|
|
|
|
|
| **(losses) ** |
|
(110,430) |
1,283 |
(109,147) |
(320,572) |
| etgain/(losses)oninvestments |
7 |
|
|
|
|
| **Net movement in funds ** |
|
(110,430) |
1,283 |
(109,147) |
(320,572) |
| **Balance brought forward 1 April 2020 ** |
|
1,462,348 |
220,90I |
1,683,249 |
2,003,821 |
| **Balance carried forward 31 March 2021 ** |
10,11 |
1,351,918 |
222,184 |
1,574,I02 |
1,683,249 |
|
|
**2021 ** |
|
**2020 ** |
|
|
**Note ** |
£ |
£ |
£ |
£ |
| **FIXED ASSETS ** |
|
|
|
|
|
| Tangible assets |
6 |
|
43,315 |
|
95,351 |
| Investments |
7 |
|
_1,193,498 _ |
|
1,342,633 |
|
|
|
1,236,813 |
|
1,437,984 |
| **CURRENT ASSETS ** |
|
|
|
|
|
| Debtors |
8 |
445,213 |
|
66,294 |
|
| Cashatbankandinhand |
|
74,635 |
|
359,082 |
|
|
|
_519,848 _ |
|
425,376 |
|
| **CREDITORS: Amounts falling ** |
|
|
|
|
|
| **due withinone year ** |
9 |
(182,559) |
|
(180,111) |
|
|
|
|
337,289 |
|
245,265 |
| **NETASSETS ** |
|
|
1,574,102 |
|
£1,683,249 |
| Funds: |
|
|
|
|
|
| Unrestricted |
10 |
|
1,351,918 |
|
1,462,348 |
| Restricted |
11 |
|
222,184 |
|
220,901 |
|
12 |
|
1,574,102 |
|
1,683,249 |
|
**2021 ** |
**2020 ** |
|
£ |
£ |
| **Cash from operating activities ** |
|
|
| Net cash(usedin)/by operatingactivities |
(435,310) |
(269,654) |
| **Cashflows from investing activities ** |
|
|
| Purchaseoffixedassets |
(390) |
|
| Saleofinvestments |
|
|
| Purchaseofinvestments |
|
|
| Investmentincomereceived |
2,118 |
10,592 |
|
1,728 |
10,592 |
| (Decrease)/increaseincashandcashequivalentsintheyear |
(433,582) |
(259,062) |
| Cashandcashequivalentsatthebeginning oftheyear |
|
|
|
1,701,715 |
1,960,777 |
| Cashandcashequivalentscarriedforward |
1,268,133 |
1,701,715 |
|
====== |
|
| **Reconciliation of net (expenditure)/income tonet cash flow ** |
|
|
| **from operating activities ** |
|
|
| Netmovementinfunds |
(109,147) |
(320,572) |
| Depreciationcharge |
52,426 |
52,633 |
| Investmentincome |
(2,1I8) |
(10,592) |
| (Decrease)/increaseincreditors |
2,448 |
(398,087) |
| Decrease/(increase)in debtors |
(378,919) |
406,964 |
|
(435,310) |
(269,654) |
| **Analysis of cash and cash equivalents ** |
|
|
| Cashatbank |
74,635 |
359,082 |
| Investments heldascash |
1,193,498 |
1,342,633 |
| Totalcashandcashequivalents |
1,268,133 |
1,701,715 |
| 2. |
**EXPENDITURE ** |
**2021 ** |
**2020 ** |
|
|
£ |
£ |
| **(a) ** |
**Raising funds ** |
|
|
|
Fundraisingsalariesincludingnationalinsurance |
79,991 |
61,842 |
|
Travel,subsistenceandrelatedexpenses |
172 |
217 |
|
Events,committeemeetingsetc. |
1,191 |
1,535 |
|
Marketingandpublicrelations |
4,1224 |
4,201 |
|
Personnelcostsallocatedto Charitable&Admin |
(20,000) |
|
|
Investmentcharges |
|
5,227 |
|
|
65,478 |
73,022 |
| **(b) ** |
**Charitable activities: ** |
|
|
|
ContributiontoresearchfacilityatStGeorge'sUniversityofLondon |
|
|
|
-Staffincludingrecruitment |
509,547 |
625,869 |
|
-Consumables |
76,652 |
51,455 |
|
Symposium |
|
58,377 |
|
Personnelcostsallocatedtocharitableexpenditure |
10,000 |
|
|
Conference,travelandsubsistence |
150 |
4,861 |
|
Legalandprofessionalfees-patent |
|
3,690 |
|
Equipmentmaintenance |
11,948 |
1,990 |
|
Equipmentdepreciation |
51,032 |
51,032 |
|
|
659,329 |
797,274 |
|
**Support ** |
|
|
|
Rent,rates,andutilities |
21,752 |
21,082 |
|
Telephone,printing,postage andstationery |
11,785 |
15,451 |
|
Insurance |
2,437 |
2,127 |
|
Bankandinvestment charges |
3,353 |
265 |
|
Professionalfees |
13 |
12,518 |
|
Depreciation |
1,394 |
1,601 |
|
Personnelcostsallocatedto administration |
10,000 |
|
|
Governance-Otherprofessionalcosts |
4,000 |
4,660 |
|
Governance-Accountancy andaudit |
14,638 |
13,003 |
|
|
69,372 |
70,707 |
|
Total |
794,179 |
941,003 |
| 3. |
**STAFF COSTS ** |
**2021 ** |
**2020 ** |
|
|
£ |
£ |
|
Wagesandsalaries |
73,711 |
73,512 |
|
SocialSecurityCosts |
3,748 |
4,763 |
|
Pensioncontributions |
3,211 |
2,205 |
|
|
79,670 |
80,480 |
4. |
**'ET MOVEMENT IN FU~DS ** |
**2021 ** |
**2020 ** |
|
|
£ |
£ |
|
Thisisstatedaftercharging: |
|
|
|
Depreciation |
52,426 |
52,633 |
|
Auditors'remuneration |
7,980 |
7,750 |
| **6. ** |
**TANGIBLE FIXED ASSETS ** |
**Office furniture ** |
**Clinical ** |
|
|
|
**and equipment ** |
**equipment ** |
**Total ** |
|
|
£ |
£ |
£ |
|
**Cost ** |
|
|
|
|
AtIApril2020 |
17,176 |
276,477 |
293,653 |
|
Additionsinyear |
390 |
|
390 |
|
Disposalsin year |
(11,129) |
(I,150) |
(12.279) |
|
Asat31March2021 |
6437 |
275,327 |
28I,764 |
|
**Depreciation ** |
|
|
|
|
AtIApril2020 |
15,380 |
182,922 |
198,302 |
|
Chargefortheyear |
1,394 |
51,032 |
52,426 |
|
Eliminated ondisposal |
(11,129) |
(I,150) |
(12,279) |
|
At31March2021 |
5,645 |
232,804 |
238,449 |
|
**~ct Book Value ** |
|
|
|
|
At31March2021 |
792 |
42,523 |
43,315 |
|
At31March2020 |
1,796 |
93,555 |
95,351 |
| 7. |
**INVESTMENTS ** |
|
**2021 ** |
**2020 ** |
|
|
|
£ |
£ |
|
Marketvalue atIApril2020 |
|
1,342,633 |
1,901,958 |
|
Additions |
|
|
|
|
Disposals |
|
|
|
|
Cashwithdrawals |
|
(149,135) |
(559,325) |
|
Realisedlossonsale |
|
|
|
|
Unrealised(loss)/profit oninvestments |
|
|
|
|
Market valueat31March 2021 |
|
1,193,498 |
1,342,633 |
| 8. |
**DEBTORS ** |
**2021 ** |
2020 |
|
|
£ |
£ |
|
Prepaymentsandaccruedincome |
37,178 |
55,467 |
|
Otherdebtors |
408,035 |
10,827 |
|
|
445,213 |
66,294 |
| **9. ** |
**CREDITORS: AMOU~TS FALLl1\'G ** |
**2021 ** |
2020 |
|
**DUE WITHIN ONE YEAR ** |
£ |
£ |
|
Accrualsanddeferredincome |
177,107 |
175,650 |
|
Othercreditors |
5,452 |
4,461 |
|
|
182,559 |
180,111 |
| **10. ** |
**UNRESTRICTED FU 1DS ** |
**2021 ** |
**2020 ** |
|
|
£ |
£ |
|
**General ** |
|
|
|
AtIApril2020 |
1,462,348 |
1,729,036 |
|
(Deficit)forthefinancialyear |
(110,430) |
(266,688) |
|
At31March 2021 |
1,351,918 |
1,462,348 |
| 11. |
**RESTRICTED FUNDS ** |
**Balance at ** |
|
|
**Balance at ** |
|
|
1April |
|
|
**31 March ** |
|
|
2020 |
Income |
**Expenditure ** |
**2021 ** |
|
|
£ |
£ |
£ |
£ |
|
Prostate CancerResearch |
176,432 |
|
|
176,432 |
|
Ovarian |
42,947 |
1,562 |
|
44,509 |
|
Pancreatic |
1,522 |
|
(1,522) |
|
|
SeniorLecturerAssociate |
|
20,413 |
(19,170) |
1,243 |
|
Generalresearch |
|
433,963 |
(426,355) |
|
|
EquipmentCapital |
|
5,000 |
(5,000) |
|
|
|
220,901 |
460,938 |
(459,655) |
222,184 |
|
**RESTRICTED FUNDS ** |
**Balance at ** |
|
|
**Balance at ** |
|
|
1April |
|
|
**31 March ** |
|
|
**2019 ** |
Income |
**Expenditure ** |
**2020 ** |
|
|
£ |
£ |
£ |
£ |
|
ProstateCancerResearch |
176,432 |
|
|
176,432 |
|
Ovarian |
|
42,947 |
|
42,947 |
|
Pancreatic |
|
1,522 |
|
1,522 |
|
SeniorLecturerAssociate |
79,252 |
|
(79,252) |
|
|
Generalresearch |
13,279 |
413,076 |
(426,355) |
|
|
Symposium |
5,822 |
27,562 |
(33,384) |
|
|
|
274,785 |
485,107 |
(538,991) |
220,901 |
| **12. ** |
**ANALYSTS OF NETASSETS ** |
**General ** |
**Restricted ** |
**Total ** |
|
**BETWEEN FUNDS ** |
**Funds ** |
**Funds ** |
**2021 ** |
|
|
£ |
£ |
£ |
|
**Fund balances at31 March 2021 are represented by: ** |
|
|
|
|
Tangibleassets |
43,315 |
|
43,315 |
|
Investments |
1,193,498 |
|
1,193,498 |
|
etcurrentassets |
115,106 |
222,184 |
337,289 |
|
|
1,351,918 |
222,184 |
1,574,102 |
|
|
£ |
£ |
£ |
|
**Fund balances at 31 March 2020 are represented by: ** |
|
|
|
|
Tangibleassets |
95,351 |
|
95,351 |
|
Investments |
1,342,633 |
|
1,342,633 |
|
et currentliabilities |
24,364 |
220,901 |
245,265 |
|
|
1,462,348 |
220,901 |
1,683,249 |
|
|
**Unrestricted ** |
**Restricted ** |
**Total ** |
|
|
**Funds ** |
**Funds ** |
**Funds ** |
|
|
**2020 ** |
**2020 ** |
**2020 ** |
|
**Notes ** |
£ |
£ |
£ |
| **l~COME FROM: ** |
|
|
|
|
| **Donations and legacies ** |
|
I05,674 |
485,107 |
590,781 |
| **Charitable activities ** |
|
|
|
|
| Symposium |
|
19,058 |
|
19,058 |
| **Investment income ** |
|
10,592 |
|
10,592 |
| **Total income ** |
|
135,324 |
485,I07 |
620,431 |
| **EXPENDITURE ON: ** |
|
|
|
|
| Raisingfunds |
|
73,022 |
|
73,022 |
| Charitableactivities |
|
328,990 |
538,991 |
867,981 |
| **Total expenditure ** |
2 |
402,012 |
538,991 |
941,003 |
| **Net income/(expenditure) before investment ** |
|
|
|
|
| **(losses) ** |
|
(266,688) |
(53,884) |
(320,572) |
| Net(losses)oninvestments |
7 |
|
|
|
| **Net movement in funds ** |
|
(266,688) |
(53,884) |
(320,572) |
| Balance brought forward IApril20 I9 |
|
1,729,036 |
274,785 |
2,003,821 |
| **Balance carried forward 31 March 2020 ** |
10,11 |
1,462,348 |
220,901 |
1,683,249 |